GLP-1-based therapies: the dilemma of uncertainty.
Gastroenterology · 2011
Last updated 2026-05-28| Journal | Gastroenterology, 2011 |
|---|---|
| Citations | 40 |
| Relative citation ratio | 1.28 |
| NIH percentile | 59 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes, Obesity, Cardiovascular Risk Reduction, Chronic Kidney Disease, Mash, Heart Failure |
Full record and abstract on PubMed 21723985 ↗